Aging into Medicare tied to higher drug costs for people with diabetes
Jul 17, 2024
Quarterly out-of-pocket costs increased by approximately $23, on average, after age 65.
Disparities in post-acute stroke care depend on insurance status
Jul 17, 2024
Uninsured patients had the lowest odds of facility versus home discharge and home healthcare discharge versus home without home healthcare.
New federal rule means hospitals need written consent for pelvic, prostate exams
Apr 01, 2024
The HHS also issued a new set of guidelines clarifying a longstanding requirement that hospitals must obtain written informed consent as a condition for being reimbursed by Medicare and Medicaid.
Outpatient care has shifted toward more specialist care for Medicare recipients
Nov 01, 2021
“We find that during the past 20 years, healthcare for Medicare beneficiaries is increasingly fragmented across several physicians, mostly specialists, with little change in annual engagement with...
Greater nurse staffing tied to better sepsis outcomes
Jun 01, 2022
An increase in registered nurse hours per patient day was associated with a 3% decrease in 60-day mortality.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Seniors report medical care missed during the pandemic
Dec 30, 2021
The rates of forgone medical care because of COVID-19 decreased over time; about 70% of forgone care was due to physician-driven factors.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
Pricey Alzheimer drug drives spike in Medicare B premium: Officials
Nov 15, 2021
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.